PYC THERAPEUTICS LIMITED — Director's Dealing 2017

Jun 18, 2017

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity PHYLOGICA LIMITED ABN 48 098 391 961

We, Phylogica Limited, give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	BERNARD EDWARD FREDERICK HOCKINGS
Date of last notice	23 JANUARY 2017

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	INDIRECT
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.
Date of change	16 JUNE 2017
No. of securities held prior to change	DIRECT- 57,875,592 ORDINARY SHARESINDIRECTDR BERNARD EDWARD HOCKINGS &MRS DIANNE CHRISTINE HOCKINGS(BHOCKINGS PRIVATE S/F 2 A/C)- 521,585,293 ORDINARY SHARESALEXANDRA HOCKINGS(Daughter)- 35,708,172 ORDINARY SHARESJAMES HOCKINGS(Son)- 755,128 ORDINARYSHARES
Class	ORDINARY SHARES
Number acquired	NIL
Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestmentplan, participation in buy-back

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

	Number disposed	Number disposed	Number disposed	Number disposed	33,000,000	33,000,000	33,000,000	33,000,000
	Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation				$990,000
	No. of securities held after change				DIRECT
					- 65,018,449	ORDINARY SHARES
					INDIRECT
					DR BERNARD	EDWARD HOCKING	S &
					MRS DIANNE C	HRISTINE HOCKIN	GS
					(BHOCKINGS-514442436	RIVATE S/F 2 A/C)ORDINARY SHAR	ES
					,,
					ALEXANDRA H(Dht)	OCKINGS
					auger- 2708172 O	RDINARY SHARES
					,,JAMES HOCK	NGS
					(Son)
					- 755,128 OR	DINARYSHARES

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	CALL OPTION AT $0.03 PER SHARE ONOR BEFORE 18 JULY 2017
Nature of interest	INDIRECT
Name of registered holder(if issued securities)	ALEXANDRA HOCKINGS
Date of change	19 JANUARY 2017
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract in relation to which theinterest has changed	35,708,172 ORDINARY SHARES
Interest acquired	NIL
Interest disposed	33,000,000
Value/ConsiderationNote: If consideration is non-cash, provide details and an estimatedvaluation	$990,000
Interest after change	2,708,172ORDINARYSHARES

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailedabove traded during a+closed period where priorwritten clearance was required?	NO
If so, was prior written clearance provided to allow thetrade to proceed during this period?	N/A
If prior written clearance was provided, on what datewas this provided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011